VC  NeuroVentures Capital

http://www.neuroventures.com





     Office Locations:

Zero Court Square
Charlottesville, VA 22902
Phone: 434-297-1000
Fax: 434-297-1001

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2000, NeuroVentures Capital, LLC is a specialty venture capital firm that invests in emerging biopharmaceutical and medical technology companies that are developing novel therapies to address the tremendous unmet medical needs in Central Nervous System (CNS) diseases and disorders. NeuroVentures has capital commitments in excess of $15 million and is led by a team of experienced venture capital and life science professionals, and advised by an internationally recognized network of medical and scientific thought leaders. NeuroVentures Fund is a targeted $20 million venture capital fund dedicated primarily to investing in companies engaged in the development and marketing of drugs, devices, therapeutics, diagnostics and other medical products and technologies for neuroscience markets. NeuroVentures focuses on early-stage investments in the range of $200,000 to $2,000,000, and plays a highly active role in the development of its portfolio companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Daniel J. O'Connell Managing Partner
    Mark A. Cochran Ph.D. Founding Partner

     

    Portfolio companies include:


      Acumen Pharmaceuticals
        web link


      BrainCells
        web link


      Concentric Medical
        web link


      EnVivo Pharmaceuticals
        web link


      Kadmus Pharmaceuticals
        web link


      NeurAxon
        web link


      Rivanna Pharmaceuticals
        web link


      Saegis Pharmaceuticals
        web link


      Scion Pharmaceuticals
        web link


      Setagon
        web link


      SpineWave
        web link


     

    Recent News: